I would be curious if someone ran a health economics analysis on lockdowns.
The UK sets the value of 1 quality adjusted life year (QALY) at 20-30k GBP. Basically, if a new medical technology costs more than that they say “no, it’s not worth it” (though there are exceptions).
It shouldn’t be hard to figure out the cost of the shutdown and divide it by the number of QALYs gained.